MB310 has been developed as an oral capsule, dosed once daily, containing a defined consortium of eight live gut commensal ...

(formerly JNJ-2113) milestone earned in Q4 2024, received in January 2025PN-881, a potential best-in-class oral IL-17 receptor antagonist peptide nominated as a development candidate in Q4 2024Topline ...

Teva Pharmaceuticals and Alvotech said on Friday they have launched a biosimilar to Johnson & Johnson's autoimmune drug Stelara in the United States. Selarsdi, like Stelara, is approved for the ...

(formerly JNJ-2113) milestone earned in Q4 2024, received in January 2025PN-881, a potential best-in-class oral IL-17 receptor antagonist peptide nominated as a development candidate ...

Weight loss in teenagers always needs attention. In addition to continued height and weight growth, their internal organs are still growing and their bones and brains are still developing.

Factors linked to C difficile infection in patients with IBD include IBD activity prior to infection, shorter disease ...

Seer's management is scheduled to participate in a fireside chat on Tuesday, March 4 th at 11:50 a.m. Eastern Time / 8:50 a.m. Pacific Time. A live webcast of the session will be available on the ...